Literature DB >> 9192918

The source and role of RANTES in interstitial lung disease.

M Petrek1, P Pantelidis, A M Southcott, P Lympany, P Safranek, C M Black, V Kolek, E Weigl, R M du Bois.   

Abstract

The chemokine "regulated on activation, normal T-cell expressed and secreted" (RANTES) is a potent eosinophil and lymphocyte attractant with particular preference for CD45RO+ T-cells and eosinophils. These cells accumulate in the lungs of patients with sarcoidosis and fibrosing alveolitis. The purpose of this study was to determine whether RANTES mediates the inflammatory cell influx in these diffuse lung diseases. Cell types and number of bronchoalveolar cells expressing RANTES protein were investigated by immunocytochemistry using lavage cells obtained from 22 patients and 11 control subjects. Subsequently, RANTES messenger ribonucleic acid (mRNA) was semiquantitated using reverse transcription polymerase chain reaction (RT-PCR) methodology in unseparated lavage cell pellets in 26 patients and 13 control subjects. Cells expressing RANTES mRNA were identified by in situ hybridization. RANTES protein expression in lower respiratory tract (LRT) cells was identified in all study groups. The percentage of RANTES+ lavage cells in sarcoidosis was higher than in controls. RANTES was localized in the cytoplasm, mainly in alveolar macrophages (CD68+ cells) in sarcoidosis, and both in alveolar macrophages and eosinophils in fibrosing alveolitis. The same cell types which expressed RANTES protein expressed RANTES mRNA, as assessed by in situ hybridization. Sarcoidosis patients had higher levels of RANTES mRNA than the other groups. RANTES protein was higher in individuals with abnormal lymphocyte numbers: RANTES protein and mRNA expression was significantly correlated with lavage CD45RO+ lymphocyte numbers. These results indicate that RANTES may mediate T-lymphocyte influx in diffuse lung disease, particularly sarcoidosis. Moreover, they suggest that the cellular source of RANTES is the alveolar macrophage in sarcoidosis, and both macrophages and eosinophils in fibrosing alveolitis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9192918     DOI: 10.1183/09031936.97.10061207

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  12 in total

Review 1.  Lung fibrosis.

Authors:  C Fonseca; D Abraham; C M Black
Journal:  Springer Semin Immunopathol       Date:  1999

2.  Fas/FasL and perforin/granzyme pathway in acute rejection and diffuse alveolar damage after allogeneic lung transplantation-a human biopsy study.

Authors:  Iris Bittmann; Christian Müller; Jürgen Behr; Jan Groetzner; Lorenz Frey; Udo Löhrs
Journal:  Virchows Arch       Date:  2004-07-29       Impact factor: 4.064

3.  CD40 ligand (CD154) stimulation of macrophages to produce HIV-1-suppressive beta-chemokines.

Authors:  R S Kornbluth; K Kee; D D Richman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

4.  Viral regulation of RANTES expression during human cytomegalovirus infection of endothelial cells.

Authors:  M Billstrom Schroeder; G S Worthen
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

5.  Steroid-sparing effects of pentoxifylline in pulmonary sarcoidosis.

Authors:  M K Park; H Babaali; L I Gilbert-McClain; M Stylianou; J Joo; J Moss; V C Manganiello
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2009-07       Impact factor: 0.670

6.  Inflammatory profile and response to anti-tumor necrosis factor therapy in patients with chronic pulmonary sarcoidosis.

Authors:  Matthew J Loza; Carrie Brodmerkel; Roland M Du Bois; Marc A Judson; Ulrich Costabel; Marjolein Drent; Mani Kavuru; Susan Flavin; Kim Hung Lo; Elliot S Barnathan; Robert P Baughman
Journal:  Clin Vaccine Immunol       Date:  2011-04-20

7.  Chemokine production and leukocyte recruitment to the lungs of Paracoccidioides brasiliensis-infected mice is modulated by interferon-gamma.

Authors:  Janeusa T Souto; Júlio C Aliberti; Ana P Campanelli; Márcia C Livonesi; Cláudia M L Maffei; Beatriz R Ferreira; Luiz R Travassos; Roberto Martinez; Marcos A Rossi; João S Silva
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

8.  Expression of CC and CXC chemokines and chemokine receptors in human leprosy skin lesions.

Authors:  A A Kirkaldy; A C Musonda; S Khanolkhar-Young; S Suneetha; D N J Lockwood
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

9.  Immune response CC chemokines CCL2 and CCL5 are associated with pulmonary sarcoidosis.

Authors:  Vyacheslav Palchevskiy; Nastran Hashemi; Stephen S Weigt; Ying Ying Xue; Ariss Derhovanessian; Michael P Keane; Robert M Strieter; Michael C Fishbein; Jane C Deng; Joseph P Lynch; Robert Elashoff; John A Belperio
Journal:  Fibrogenesis Tissue Repair       Date:  2011-04-04

10.  In vitro pharmacoregulation of CC chemokine ligand 5 and its receptor CCR5 in diffuse lung diseases.

Authors:  Veronika Sekerova; Daniela Subrtova; Frantisek Mrazek; Agata Gibejova; Vitezslav Kolek; Roland M du Bois; Martin Petrek
Journal:  Mediators Inflamm       Date:  2003-08       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.